VYNE Therapeutics
VYNE
#9861
Rank
A$33.55 M
Marketcap
$2.21
Share price
-2.08%
Change (1 day)
-45.13%
Change (1 year)

Earnings for VYNE Therapeutics (VYNE)

Earnings in 2024 (TTM): -A$66.32 Million

According to VYNE Therapeutics's latest financial reports the company's current earnings are A$0.5 Million. a decrease over its 2023 earnings that were of -A$45.79 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for VYNE Therapeutics from 2017 to 2024

Annual earnings

Year Earnings Change
2024 -A$68.28 Million49.14%
2023 -A$45.79 Million-14.09%
2022 -A$53.3 Million-19.38%
2021 -A$66.1 Million-83.2%
2020 -A$0.4 Billion229.89%
2019 -A$0.12 Billion39.8%
2018 -A$85.33 Million84.29%
2017 -A$46.31 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.23 Billion 227.46%๐Ÿ‡บ๐Ÿ‡ธ USA